Novo Nordisk reported results on its next-generation obesity drug in diabetes patients, including data on weight loss that ...
Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...
Hosted on MSN20d
A Novo Nordisk weight loss drug lowers BMI in kids as young as 6In a late-stage clinical trial, a drug similar to Ozempic was shown to reduce body mass index in kids ... of Novo Nordisk’s older GLP-1 drugs: Saxenda, a weight loss drug, and Victoza, a ...
South Africa's competition watchdog is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive ...
Novo Nordisk A/S and Sanofi are facing an investigation in South Africa over concerns about potential anti-competitive practices in the human insulin pen market.
Shares of Novo Nordisk (NVO) are sliding in Monday trading after the company announces results for its trial of weight-loss drug CagriSema.
Hikma Pharmaceuticals (HKMPF) is in talks with partners across the world to prepare to sell a generic version of Ozempic and Wegovy, as patents ...
the active ingredient in Wegovy as well as diabetes drug Ozempic. The FDA had listed semaglutide in shortage for more than two years as Novo Nordisk struggled to meet the seemingly bottomless ...
Novo Nordisk A/S and Sanofi are facing an investigation in South Africa over concerns about potential anti-competitive practices in the human insulin pen market. South Africa’s Competition ...
South Africa's competition watchdog is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive practices in the human insulin pen market, the authority said on Tuesday.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback